Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.53% INR873.35
America/New_York / 8 mai 2024 @ 06:00
FUNDAMENTALS | |
---|---|
MarketCap: | 118 817 mill |
EPS: | 28.32 |
P/E: | 30.84 |
Earnings Date: | May 15, 2024 |
SharesOutstanding: | 136.05 mill |
Avg Daily Volume: | 0.179 mill |
RATING 2024-05-08 |
---|
A- |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 30.84 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 30.84 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
INR764.36 (-12.48%) INR-108.99 |
Date: 2024-05-08 |
Expected Trading Range (DAY) |
---|
INR 851.24 - 895.46 ( +/- 2.53%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | INR873.35 (0.53% ) |
Volume | 0.102 mill |
Avg. Vol. | 0.179 mill |
% of Avg. Vol | 57.20 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.